These trials matter because they remove the confounding variable of high blood sugar, which independently increases UTI risk in diabetic populations
A new Ozempic-like weight loss medication (i.e., GLP-1 receptor agonist) has been found safe and effective for obesity or overweight treatment
Antioxidant and Anti-aging Protection Neutralizes free radicals that damage skin and cells
Scientists have questioned whether differences in age, race, or starting weight might explain why some patients lose more weight than others
Compared to the placebo (-4.0), liraglutide resulted in a greater change in BMI as a percentage of the 95th percentile (-14.0), and an estimated treatment difference of 10.0 (95% CI, 15.1 to 4.8) was observed
How PlexusDx Supports a More Personalized Approach PlexusDx recognizes that GLP-1 treatment response and plasma donation eligibility are interconnected through individual health profiles